Literature DB >> 3769204

Analysis of conjugated and unconjugated bile acids in serum and jejunal fluid of normal subjects.

A Tangerman, A van Schaik, E W van der Hoek.   

Abstract

A reliable method is described for the determination of conjugated and unconjugated bile acids in serum and jejunal fluid. Bile acids are extracted using reverse-phase octadecylsilane bonded silica cartridges and are separated into their unconjugated and conjugated fractions using the lipophilic anion exchanger diethylaminohydroxypropyl Sephadex LH-20 (DEAP-LH-20). The conjugated fraction can be separated into a glycine and a taurine fraction, using the same anion exchanger. The bile acids are measured using a hydroxysteroid dehydrogenase-fluorimetric assay for serum and a hydroxysteroid dehydrogenase-photometric assay for jejunal fluid. The normal fasting serum value of total 3 alpha-hydroxy bile acids amounts to 3.5 +/- 2.8 mumol/l (mean +/- SD, range 1.4-10.8, n = 22). The corresponding unconjugated bile acid fraction amounts to 39.9 +/- 11.2% (range 20.7-64.6%) of total bile acids. The concentration of conjugated bile acids became significantly elevated 30, and 60 min after a standard meal, whereas that of unconjugated bile acids remained unchanged. In jejunal fluid only conjugated bile acids are found, as well in fasting subjects as postprandial, 30 or 60 min after a standard meal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3769204     DOI: 10.1016/0009-8981(86)90044-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

1.  Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.

Authors:  Hannah M Jones; Neil Parrott; Gerd Ohlenbusch; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products.

Authors:  Dimitrios G Fatouros; Isabelle Walrand; Bjorn Bergenstahl; Anette Müllertz
Journal:  Pharm Res       Date:  2008-11-12       Impact factor: 4.200

Review 3.  Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms.

Authors:  J B Dressman; G L Amidon; C Reppas; V P Shah
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

4.  Characterization of fluids from the stomach and proximal jejunum in men and women.

Authors:  A Lindahl; A L Ungell; L Knutson; H Lennernäs
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

5.  Identification of Two Sulfated Cholesterol Metabolites Found in the Urine of a Patient with Niemann-Pick Disease Type C as Novel Candidate Diagnostic Markers.

Authors:  Masamitsu Maekawa; Kaoru Omura; Shoutaro Sekiguchi; Takashi Iida; Daisuke Saigusa; Hiroaki Yamaguchi; Nariyasu Mano
Journal:  Mass Spectrom (Tokyo)       Date:  2016-11-25

6.  Abnormal leukotriene C4 released by unaffected jejunal mucosa in patients with inactive Crohn's disease.

Authors:  F Casellas; F Guarner; M Antolín; R Rodríguez; A Salas; J R Malagelada
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

7.  Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).

Authors:  E Jacquemin; M Dumont; O Bernard; S Erlinger; M Hadchouel
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

8.  The effects of bile salts and lipids on the physicochemical behavior of gemfibrozil.

Authors:  P E Luner; S R Babu; G W Radebaugh
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

9.  Solubilization and wetting effects of bile salts on the dissolution of steroids.

Authors:  V Bakatselou; R C Oppenheim; J B Dressman
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

10.  Deconjugation of bile acids by lactobacilli in the mouse small bowel.

Authors:  G W Tannock; A Tangerman; A Van Schaik; M A McConnell
Journal:  Appl Environ Microbiol       Date:  1994-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.